US Patent Issued to GLIAPHARM on April 15 for "Compositions and methods of treatment for neurological disorders comprising a dementia" (Swiss Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,274,703, issued on April 15, was assigned to GLIAPHARM SA (Geneva).

"Compositions and methods of treatment for neurological disorders comprising a dementia" was invented by Sylvain Lengacher (Geneva), Charles Finsterwald (Geneva) and Pierre Magistretti (Geneva).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention, in at least some embodiments, relates to an inventive molecule, compositions comprising same, and methods of use thereof for treatment of a neurological disorder."

The patent was filed on Aug. 24, 2021, under Application No. 17/409,834.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov...